Home / Prepare Your Business for Sale / Optometry Practice

How to Prepare Your Optometry Practice for a Sale or Exit in 2026: The 36-Month PE-Buyer Playbook

Preparing your optometry practice for exit in 2026 is a 36-month playbook. The first 12 months tighten the operating story around exam volume, optical mix, and vision-plan reimbursement, the middle 12 fix pre-LOI diligence gaps around OD retention and equipment condition, and the final 12 turn one offer into a real competitive process where multiple optometry consolidators decide the outcome.

An optometry practice is three businesses under one roof: a medical clinic that bills insurers, a retail optical shop that sells frames, lenses and contact lenses, and a staffing operation that depends on finding and keeping doctors. A buyer prices each of them separately and then asks how much of the whole depends on you. This guide is for owner ODs who expect to sell or partner in the next one to three years. It covers who buys optometry practices today, the federal and state rules that come up in diligence, the vision plan and staffing questions buyers ask first, and a preparation timeline that works backward from the day you start talking to buyers.

Updated October 2026 · CT Acquisitions

The optometry practices that sell well are rarely the biggest ones. They are the ones where a buyer can see, quickly and in writing, that the business will keep running without the founder in the exam lane every day. That means associate ODs who are staying, an optical that sells to patients the practice already sees, payer contracts that will survive a change of ownership, and prescription and billing records that pass an audit. None of that can be fixed in the few months between a first buyer meeting and a letter of intent, which is why preparation starts years earlier.

Where we cite a figure, we name the source in the same sentence. Where public data does not exist, for example on private deal multiples for small practices, we describe what drives price rather than quote numbers we cannot verify.

Who buys optometry practices in 2026

An owner OD has more types of buyer than most medical specialists, and they want different things. Knowing which group you are selling to shapes everything from how you present the optical to how long you will be asked to keep seeing patients.

Associate ODs and neighboring practices

The traditional exit is still common: an associate buys in over time, or a nearby practice acquires the patient base and records. These buyers know the local market and the patients, and they usually keep the practice name. Their constraint is capital. An individual OD buying a practice relies on bank financing and often on seller financing, so the price has to be supportable from the practice’s own cash flow after covering a doctor’s salary for the new owner. If you want this route, the preparation is about clean books a lender accepts and a transition plan that keeps patients loyal.

OD-focused management service organizations

Private equity-backed groups that partner with optometry practices are now a standard part of the buyer field. Two examples show the scale. Keplr Vision’s website reports 250+ managed practice clinics with 600+ optometrists in 35 states, and its practice map plots 254 practices across those states. EyeCare Partners’ website lists 700+ optometrists, 300+ ophthalmologists and 30+ surgery centers across 18 states. These groups typically buy a majority of the practice, centralize billing, purchasing, recruiting and marketing, and ask the selling doctor to keep practicing under an employment agreement for a set period. Many offer equity in the parent company as part of the price, so you share in the group’s future sale.

Ophthalmology-led platforms

Groups built around ophthalmology practices and surgery centers also employ optometrists, because ODs refer surgical cases and manage medical eye care. EyeSouth Partners says it began as a single practice in February 2017 and now has 70 practice affiliations, more than 400 doctors and 285 locations, including 26 surgery centers across 16 states, with 1.5 million annual patient visits. American Vision Partners lists practices in Arizona, New Mexico and Nevada, including Barnet Dulaney Perkins Eye Center and Southwestern Eye Center. Vision Innovation Partners describes itself as supporting mid-Atlantic ophthalmology practices and surgery centers with the backing of a middle-market private equity firm, handling compliance, managed care contracting, finance and practice management. For an OD practice, these buyers value medical eye care volume and referral relationships more than optical sales.

Healthcare strategics

The largest recent eye care deals were made by drug distributors buying ophthalmology groups. Cencora acquired 85% of Retina Consultants of America for approximately $4.4 billion on January 2, 2025, and McKesson signed a definitive agreement in February 2025 to acquire an 80% interest in PRISM Vision Holdings. Neither deal involved a stand-alone optometry practice, but they matter to OD sellers in two ways. They show that large corporate buyers are willing to pay for scale in eye care, which supports the value of the platforms that buy OD practices. And they explain why ophthalmology-led groups are keen to add optometrists who generate medical referrals.

Vertically integrated eye care companies

Some of the largest companies in eye care sit on several sides of your business at once. According to Wikipedia’s summary of EssilorLuxottica, the group owned 1,098 LensCrafters locations, 549 Pearle Vision locations plus 713 under the Pearle name, and 591 Target Optical locations in 2025, owns the vision benefits company EyeMed, and acquired 80% of OCT maker Heidelberg Engineering in July 2024. VSP Vision Care, founded in 1955 in Oakland by a group of optometrists and now headquartered in Rancho Cordova, served about 85 million members in 2017, acquired the optical retailer Visionworks in 2019 and bought Marchon Eyewear in 2008 for $735 million. For a practice owner, that means a vision plan you depend on may also own the frames you sell and the retail chain down the street. Buyers will want to know how exposed your revenue is to any one of these relationships.

Comparing the buyer types side by side

The workforce numbers behind every optometry deal

A buyer of an optometry practice is buying a team of doctors and opticians, and the labor market decides how hard that team is to keep or replace.

The Bureau of Labor Statistics counted 45,100 optometrist jobs in 2025 with a median pay of $136,570 a year as of May 2025. It projects employment to grow 10% between 2025 and 2035, an increase of 4,300 jobs, with about 2,000 openings a year. BLS reports that 61% of optometrists work in offices of optometrists, 14% in offices of physicians and 13% in retail, while only 5% are self-employed. Wikipedia’s summary of the profession notes that Canada recognizes degrees from the twenty US optometry schools, which gives a sense of how small the training pipeline is relative to the number of practices competing for graduates.

Opticians matter almost as much, because they run the optical. BLS counted 74,300 optician jobs in 2025, with median pay of $47,260 as of May 2025, projected growth of 4% to 2035 and about 5,600 openings a year. It reports that 43% of opticians work in offices of optometrists, 23% at general merchandise retailers, 20% at health and personal care retailers and 8% in offices of physicians. Some states require opticians to be licensed, which affects how easily a buyer can move staff between locations.

What this means in a sale:

• Associate ODs are the asset buyers worry about most. With most ODs employed rather than self-employed, an associate who leaves after closing has plenty of other employers to go to. Buyers will look at associate tenure, compensation against the market and whether associates have been told about the sale.
• Owner production is a risk measure. The more of the practice’s collections come from the selling doctor, the more the buyer depends on that doctor staying. Buyers deal with this through longer employment commitments, deferred payments or a lower price.
• The optical team is part of the value. An optician team that sells well to the practice’s own patients turns an exam into a larger transaction. If that team turns over after closing, optical revenue usually falls first.

The practical step is to start recruiting and retaining associates well before a sale. A practice that adds an associate and lets that doctor build a patient base for a couple of years before marketing is a much easier sale than one that hires a doctor in the months before a buyer arrives.

What buyers pay for in an optometry practice, and what they discount

There is no public dataset of private optometry deal prices, and the ranges quoted online vary widely, so we will not repeat them here. What is consistent across buyer types is the list of things that raise or lower the price within whatever range applies to your practice.

Things that raise the price

• Doctors other than you. Associates who produce a meaningful share of collections, are under contract and plan to stay.
• Medical eye care. Exams billed to medical insurance for conditions such as dry eye, glaucoma and diabetic eye disease, supported by diagnostic equipment and good documentation. Medical revenue is less exposed to vision plan fee schedules and is what ophthalmology-led buyers value most.
• An optical that captures your own patients. The share of exam patients who buy eyewear from you, and the margin on what they buy, often decides how much profit the practice really makes.
• Specialty services. Programs such as myopia management, specialty contact lenses, dry eye treatment or vision therapy that bring in patients and revenue a commodity practice does not have.
• Recurring patients. A recall system that brings patients back on schedule, annual supplies of contact lenses and, where offered, membership plans that pay monthly.
• Clean, accrual-based books. Monthly financials that separate exam, optical and contact lens revenue, with owner expenses clearly identified.

Things that lower the price

• Founder dependence. A practice where the owner sees most patients, manages the optical and handles payer relationships is worth less to any buyer.
• Payer concentration. Heavy reliance on a single vision plan, especially one whose parent company competes with you in retail or supplies your frames.
• Compliance gaps. Missing prescription release records, weak coding documentation or unscreened staff.
• A lease that does not transfer. A lease close to expiry, with personal guarantees or a landlord consent requirement the landlord can withhold.
• Inventory problems. Frame stock that is old, overvalued on the books or held on consignment terms the buyer must take over.

Buyers also value practices differently by structure. An individual OD will usually price from the practice’s cash flow after a doctor’s salary. A management service organization prices from adjusted earnings and will pay more for a practice that fits its geography and can absorb shared services. A strategic or ophthalmology-led buyer may pay for referral value that does not show up in your own profit. Running a process that reaches more than one type of buyer is the most reliable way to find out which of those views produces the best result for you.

The optical: how buyers analyze your dispensary

For most independent practices the optical is where profit is made or lost, and buyers analyze it in detail. A practice can have a full exam schedule and still earn little if patients take their prescriptions elsewhere, or if the optical sells at thin margins.

A buyer will want to understand:

• Capture. What share of patients who receive an eyeglass prescription buy eyewear from your optical, and how that has changed over time. Present it by doctor and by location if you have more than one, because differences between doctors usually point to how the hand-off from exam lane to optical is handled.
• Revenue per optical sale. The average value of a complete pair, the mix of lens options such as progressives, coatings and second pairs, and how much is paid by vision plan allowances versus the patient.
• Gross margin. Cost of goods for frames, lenses and lab services, and how purchasing terms with suppliers affect it. A buyer with group purchasing will look at whether it can improve your margins, but it will not pay you for improvements it makes itself.
• Remakes and returns. How often orders are remade and why. High remake rates point to process or lab problems that cost money.
• Inventory turnover. How quickly frame stock sells, how much is older than a year or two, and whether any of it is on consignment.

The work before a sale is to measure these consistently for at least a couple of years, so a buyer sees a trend rather than a single snapshot. If capture or margin is weak, small changes in how doctors hand patients to opticians, how frame boards are curated and how lens options are explained often make a visible difference within a year. Those changes are worth making, because a buyer will price the optical on what it sees in your figures, not on what it could become.

Contact lenses and annual supplies

Contact lens patients are some of the most valuable in a practice, because they return for fittings and renewals and can buy their supplies from you. They are also the patients most affected by the Contact Lens Rule, which requires you to hand over their prescription and to respond to verification requests from outside sellers.

Buyers look at the share of contact lens patients who buy annual supplies from the practice, the margin on those sales, and how the practice competes with online sellers on price and convenience. They also look at how prepaid annual supplies are recorded. Cash collected for lenses not yet shipped, or for rebates still to be claimed, is a liability, and a practice that books it all as revenue on the day of sale will see its earnings adjusted in diligence. Setting up the correct accounting a year or two before a sale avoids that adjustment and makes your contact lens revenue easier for a buyer to trust.

Specialty services and how to present them

Specialty programs set a practice apart and often bring in patients by referral rather than by vision plan. Common examples are myopia management for children, specialty and scleral contact lenses, dry eye treatment, vision therapy and low vision care. They tend to be private pay or medically billed, and they depend on specific doctors, equipment and training.

When presenting specialty services to a buyer, separate them clearly in your financials: revenue, direct costs, the doctors and staff involved, and the equipment used. Show where patients come from, whether referrals from pediatricians, other optometrists or ophthalmologists, or direct marketing. A buyer will value a specialty program more if it is run by more than one doctor, has documented protocols and has grown steadily, and less if it depends entirely on the selling OD’s personal reputation.

If you plan to launch a specialty program before selling, start early. A program that has run for a couple of years with a track record of patient volumes is an asset. One launched in the months before a sale is a cost with an uncertain return in the buyer’s eyes.

Recall, retention and the patient base

A buyer of an optometry practice is buying future visits. The best evidence of future visits is how reliably current patients come back.

Prepare a clear picture of your active patient base: how many patients were seen in the last one, two and three years, how many new patients arrive each month and from where, and what share of patients due for a recall exam come back. Break it down by doctor and location if relevant. Show how the recall system works, whether reminders are automated, which channels are used and how quickly staff follow up with patients who do not respond.

Two common problems lower a buyer’s confidence. The first is an inflated active patient count that includes patients who have not been seen for years. The second is patient loyalty tied to one doctor, especially the seller, with no plan to introduce those patients to other doctors. Cleaning the data and spreading patients across doctors well before a sale addresses both.

Medical eye care, scope of practice and state rules

Scope of practice is set state by state, and it affects both what your practice can earn and how a buyer with a national footprint will run it.

Wikipedia’s overview of the profession notes that US optometrists earn a four-year Doctor of Optometry degree, are regulated by state boards, and must pass national board and state jurisprudence exams. Scope varies widely: as of 2025, 14 states allow certified optometrists to perform certain laser procedures. The Centers for Medicare & Medicaid Services defines optometrists as physicians for billing purposes, which is what allows ODs to bill medical insurance for medical eye care.

Three state-level questions come up in almost every optometry deal:

• Who may own the practice. Some states restrict ownership of an optometry practice or control over clinical decisions to licensed professionals. Buyers that are not owned by ODs use management service structures in those states, where a professional entity owned by a licensed doctor holds the clinical practice and a management company provides everything else. Your attorney should confirm what your state allows before you sign a letter of intent, because the structure changes the documents you will sign and who owns what after closing.
• What your doctors are certified to do. If your practice offers procedures or prescribes medications that depend on specific state certifications, the buyer will check each doctor’s license and certifications. A practice whose medical revenue depends on one doctor’s certification carries that doctor’s departure risk.
• Optician and technician rules. Licensing for opticians varies by state, and some delegated tasks are restricted. A buyer moving staff between locations or states needs to know who can do what.

Equipment fits into the same picture. Medical eye care depends on diagnostic instruments such as OCT and visual field analyzers, and buyers will list every major device, its age, whether it is owned or leased, and how much of the practice’s medical billing depends on it. EssilorLuxottica’s purchase of 80% of Heidelberg Engineering, a maker of OCT and other diagnostic instruments, is a reminder that equipment suppliers and optical suppliers are increasingly the same companies, which can affect pricing and service terms after a change of ownership.

FTC prescription rules: a diligence item many practices overlook

Two federal rules govern how practices hand prescriptions to patients, and buyers now check compliance with both.

The FTC’s Eyeglass Rule requires prescribers to give patients a copy of their eyeglass prescription after an eye exam, without extra cost, and prohibits conditioning an exam on the purchase of eyewear. The FTC proposed on December 9, 2022 to require prescribers to obtain signed confirmation that patients received their prescription, and it published a Final Rule amending the Eyeglass Rule on June 26, 2024.

The Contact Lens Rule, which implements the Fairness to Contact Lens Consumers Act signed on December 6, 2003 and effective February 4, 2004, requires prescribers to provide a copy of the contact lens prescription at the completion of a fitting, and bars sellers from supplying lenses without either the prescription or verification. The FTC announced final amendments on June 23, 2020, published in the Federal Register on August 17, 2020. According to Wikipedia’s article on the Act, the FTC warned in May 2025 that violations of the Contact Lens Rule may bring civil penalties of up to $53,088 per violation.

Why does this matter in a sale? Because a practice that sells eyewear and contact lenses has an obvious commercial interest in keeping patients from taking prescriptions elsewhere, and a buyer that inherits the practice inherits its record. Buyers will ask:

• How the practice records that each patient received a copy of their eyeglass and contact lens prescriptions.
• Whether the practice management system stores those confirmations and for how long.
• How verification requests from outside contact lens sellers are handled and logged.
• Whether staff have been trained and whether any FTC warning letters or patient complaints have been received.

Fixing this is usually inexpensive: a documented process, a field in the practice management system and staff training. Doing it before diligence avoids an awkward conversation and a specific indemnity in the purchase agreement.

Vision plans: concentration, credentialing and plan-owned competitors

For many practices, vision plans are the largest source of patients and the biggest constraint on price. A buyer looks at them from three angles.

• Concentration. How much of the practice’s collections come from each plan. A practice heavily dependent on one plan is exposed to that plan’s fee schedule and policies, and buyers discount accordingly.
• Credentialing after closing. When ownership changes, the practice’s contracts with vision plans, medical insurers and Medicare may need to be updated or the doctors re-credentialed under the new entity. Each payer has its own process and timing. Buyers want to know in advance whether they can bill under the existing arrangements during the transition or whether there will be a gap in reimbursement.
• Plan ownership. As described above, VSP owns Visionworks and Marchon Eyewear, and EssilorLuxottica owns EyeMed alongside its retail chains. A practice that depends on a plan whose parent also runs a competing retail chain nearby has a different risk profile from one with a balanced mix of plans and medical insurers.

Preparation here is mostly analysis. Produce a report of collections by payer for the past few years, identify which contracts have assignment or change of ownership clauses, and ask your billing team what re-credentialing would involve for each payer. If one plan dominates, consider whether growing medical eye care or private-pay services over the next two years could reduce that share before you sell.

Non-competes and associate agreements after the FTC rule

The federal attempt to ban most non-compete agreements is over. On September 5, 2025, the FTC voted 3-1 to dismiss its appeals in Ryan, LLC v. FTC in the Fifth Circuit and Properties of the Villages v. FTC in the Eleventh Circuit, and to accede to the vacatur of its Non-Compete Clause Rule, after a district court found the agency lacked authority to issue it.

That leaves state law in charge, and state law varies widely. Some states sharply limit or ban non-competes for employees, others allow reasonable restrictions, and many treat restrictions given by a seller in connection with the sale of a business more favorably than restrictions on employees. For an optometry sale, two sets of agreements matter:

• Your own covenant as seller. Buyers will ask the selling OD not to compete or solicit patients for a period after closing. Because this is tied to the sale of a business, it is generally more enforceable than an employee covenant, but its scope still needs to fit your state’s rules.
• Associate ODs’ agreements. If an associate can leave and open a practice nearby with your patients, the buyer is paying for patients it may not keep. Buyers will read every associate’s agreement for its restrictive covenants, notice periods and any change of control terms.

Re-papering associate agreements is best done well before a sale, with counsel who knows your state’s law, and with real consideration for any new restriction. Doing it in the months before a sale signals to associates that something is happening and can prompt the very departures you are trying to prevent.

Coding, Medicare enrollment and exclusion screening

Medical eye care raises the value of a practice, and it also brings billing risk that a buyer will test.

• Coding and documentation. Diagnostic testing such as OCT imaging, fundus photography and visual fields must be supported by documented medical necessity and a written interpretation. A buyer’s coding review will sample charts for these services and compare your usage with what would be expected for your patient mix. Unusually high use of a particular test, or templated documentation, invites closer review.
• Medicare and Medicaid enrollment. A change of ownership must be reported to Medicare and state Medicaid programs, and the new owner’s enrollment must be in place for billing to continue. Buyers will plan the timing of these filings around the closing date.
• Exclusion screening. Federal health programs do not pay for services furnished by excluded individuals. Buyers will ask whether every doctor and staff member has been screened against federal and state exclusion lists, and how often.
• Privacy and security. Practices share patient information with optical labs, billing companies and software vendors. Buyers will ask for business associate agreements with those vendors and evidence of a security risk assessment.

An internal coding audit by an outside reviewer, done a year or more before a sale, lets you correct problems and, where needed, address overpayments on your own terms. It is one of the best investments a medically focused practice can make before going to market.

What buyers ask for before a letter of intent

Before a buyer commits to a price in writing, it asks for a package of information. Having it ready speeds up the process and makes your practice look well run. A typical first request from an optometry buyer includes:

• Financial statements. Several years of profit and loss statements plus the trailing twelve months, monthly if possible, with revenue split between professional services, optical, contact lenses and any specialty programs.
• A balance sheet. Including accounts receivable by payer and age, inventory, equipment and any debt or equipment leases.
• Adjusted earnings. A bridge from reported profit to adjusted earnings, listing each owner expense and one-time item with support. Buyers test every adjustment, so include only those you can document.
• Provider and staff roster. Anonymized names, roles, start dates, pay and employment status for every doctor, optician and staff member, with each doctor’s share of collections.
• Revenue detail. Exam volumes by type (routine and medical), average revenue per exam, optical sales per patient, contact lens annual supply rates and specialty program revenue.
• Patient data. Active patients, new patients per month, recall rates and, if you have one, membership plan enrollment.
• Payer mix. Collections by vision plan, medical insurer, Medicare, Medicaid and private pay.
• Equipment list. Every major diagnostic and optical device with its age, condition and ownership status.
• Inventory schedule. Frame and lens inventory by brand and age, with consignment arrangements identified.
• Your plans. What role you want after closing, for how long, and what you expect the practice to look like in the next few years.

A practice that can produce this list in a few days, rather than a few weeks, makes a strong first impression and gives the buyer less room to speculate.

Confirmatory diligence and why a sell-side quality of earnings review helps

After you sign a letter of intent, the buyer’s accountants, lawyers and clinical reviewers go deeper. Expect a quality of earnings review that tests your revenue and adjustments, a coding and compliance review, a legal review of leases, payer contracts and employment agreements, and an operational review of the optical, recall systems and staffing.

Two areas specific to optometry often move the price at this stage:

• Deferred revenue. Prepaid annual contact lens supplies and membership fees are cash received for products or services not yet delivered. Buyers will treat them as a liability and may adjust working capital or price for them, so account for them correctly before a sale.
• Inventory valuation. Frames carried at cost on the books may be worth much less if they are old or discontinued. A physical count and realistic valuation before marketing avoids a surprise adjustment.

Commissioning your own quality of earnings review before going to market lets you see your practice the way a buyer’s accountants will. It identifies weak adjustments, accounting problems and working capital issues while you still have time to fix them or explain them, and it gives every buyer the same reliable starting point. For practices large enough to attract management service organizations, it usually pays for itself by reducing the price changes that follow diligence.

Your lease and your building

Location matters more in optometry than in many other healthcare businesses, because patients choose practices close to home or work and opticals depend on visibility. A buyer will read your lease closely.

• Remaining term. A lease close to expiry puts the landlord in a strong position at renewal and gives the buyer uncertainty. Extending the lease, or securing renewal options, before a sale is often worthwhile.
• Assignment and change of control. Many leases require landlord consent to assignment or to a change in ownership of the tenant. Know what your lease says and how long consent typically takes.
• Personal guarantees. If you personally guaranteed the lease, negotiate how that guarantee will be released or replaced at closing.
• Build-out and equipment. Who owns leasehold improvements and fixed equipment, and what must be restored at the end of the lease.

If you own the building through a separate entity, decide early whether to sell it, keep it and lease it to the buyer, or sell it to a real estate investor. Keeping it can provide steady income after the sale, but the lease you sign with the buyer will set the property’s value, so it deserves the same care as the practice sale itself.

Practice management systems and patient records

Buyers increasingly integrate acquired practices onto their own practice management and electronic health record systems. That makes your software and data a practical diligence item.

Expect questions about which systems you use for scheduling, records, billing, optical orders and imaging; whether data can be exported in a usable form; how long records are retained; and whether your contracts with software vendors can be assigned or terminated. Data quality matters as much as the system itself. Duplicate patient records, missing insurance information and inconsistent coding make migration harder and raise doubts about reported figures. Cleaning up patient records and confirming that imaging and test results are stored in a retrievable form are tasks that take months, not days, so start well before a sale.

Tax considerations in an optometry sale

How a sale is structured affects what you keep after tax, and optometry deals raise some specific questions to work through with your tax adviser before you agree on terms.

• Asset sale or equity sale. Buyers often prefer to buy assets for tax and liability reasons; sellers often prefer to sell equity. The choice affects how the price is taxed and which liabilities stay with you.
• Allocation of the price. In an asset sale, the price is allocated among equipment, inventory, goodwill and any non-compete or consulting payments. Each category can be taxed differently, so the allocation is a negotiation in its own right.
• Personal and practice goodwill. In some situations part of the goodwill in a professional practice may be personal to the doctor rather than owned by the practice entity. Whether that applies, and how it is documented, depends on your facts and your state.
• Rollover equity. Equity received in the buyer’s company can sometimes be structured to defer tax until it is sold. The structure has to be agreed before closing.
• Employment compensation. Payments under your post-closing employment agreement are taxed as compensation, not as sale proceeds. Buyers sometimes move value between price and salary, so compare offers on an after-tax basis.

State taxes vary, and the structure your state requires for ownership of an optometry practice can affect which options are available. Involve your tax adviser before signing a letter of intent, when the structure is still open.

Telling your associates, staff and patients

Confidentiality is harder in a small practice than in most businesses. Staff notice visitors, unusual requests for data and calls from unknown numbers. A plan for who knows what, and when, protects the value you are selling.

Most owners tell key associates and managers before diligence begins, because buyers will want to meet them and their support is part of the deal. Other staff are usually told closer to closing, with a clear message about what will and will not change. Patients are generally informed after closing, often by a letter from the selling doctor introducing the new arrangement. Buyers will want to approve these communications, and some will offer retention bonuses for key staff. Agree the plan with the buyer in advance so that nobody hears about the sale from the wrong source.

Why optometry deals fall apart

Most failed optometry deals fail for predictable reasons, and most of those reasons can be fixed in advance.

• An associate leaves during the process. The buyer was counting on that doctor’s patients and production.
• Payer credentialing problems. The buyer discovers that billing will be interrupted after closing, or that a key plan contract cannot be assigned.
• Coding findings. A chart review finds unsupported diagnostic testing, and the buyer asks for a lower price or a large escrow.
• Prescription rule gaps. The practice cannot show that patients received their prescriptions, and the buyer asks for an indemnity the seller will not give.
• Adjusted earnings do not hold up. Owner expenses or one-time items cannot be documented, and the earnings base shrinks.
• Lease problems. The landlord refuses consent or demands new terms.
• Unrealistic expectations. The seller anchors on a figure heard from a colleague and will not accept what the market offers for their specific practice.

Each of these has a fix that takes time: retaining associates, analyzing payer contracts, auditing coding, documenting prescriptions, preparing a quality of earnings review, extending the lease and testing the market with more than one buyer type. That is the argument for starting early.

Getting your bookkeeping ready for a buyer

Many independent practices keep books that work for taxes but not for a sale. Small changes made two or three years ahead make a large difference to how a buyer reads your figures.

• Use accrual accounting for management reports. Cash-basis books mix up timing, especially with insurance receivables, prepaid contact lens supplies and supplier rebates. Monthly accrual statements let a buyer see trends without reconstructing them.
• Separate revenue streams. Report professional fees, optical sales, contact lens sales and specialty services in separate lines, with matching cost of goods for the optical and contact lens lines.
• Pay yourself a market salary. If you take most of your income as distributions, or pay yourself well above or below what an employed OD would earn, a buyer will adjust your earnings. Documenting a clear, market-based salary makes the adjustment simple.
• Keep personal expenses out. Vehicles, travel, family members on payroll and other personal items running through the practice all become adjustments that a buyer must verify. The fewer there are, the more credible the rest of your figures look.
• Reconcile inventory. Count frames and lenses regularly and write down old stock, so the balance sheet reflects what the inventory is worth.
• Track receivables by payer. Age receivables by vision plan, medical insurer and patient balance, and write off what will never be collected.

These changes cost little and also make the practice easier to run in the meantime. They are the foundation for a quality of earnings review and for every conversation about price.

The transition period after closing

For most selling ODs, closing is the start of a new role rather than the end of their involvement. Planning that role is part of preparing to sell.

If you sell to a management service organization or platform, expect to keep practicing under an employment agreement for a defined period. Your schedule, compensation, clinical autonomy and responsibilities for leading other doctors should all be written into that agreement. Ask the buyer how decisions about staffing, purchasing, pricing and marketing will be made after closing, and which of those decisions will stay with you. Speak to doctors who sold to the same buyer a few years ago about how the arrangement has worked in practice.

If you sell to an associate or neighboring practice, the transition is usually shorter and focused on introducing patients and staff to the new owner. Agree in advance how long you will work, in what capacity and on what terms, and how patients will be told. A well-planned introduction protects the patient base that the buyer is paying for, and with it any deferred payments that depend on the practice’s performance.

Either way, the transition is where the value of a sale is either preserved or lost. Buyers know this, which is why a credible transition plan is one of the strongest things you can bring to the negotiation.

How optometry deals are usually structured

The headline price is only part of what you receive. Optometry deals with management service organizations and platforms tend to share a set of terms:

• Cash at closing and rollover equity. Many buyers pay most of the price in cash and the rest as equity in the parent company. That equity can be valuable if the group is later sold at a higher value, but it is illiquid and depends on the platform’s performance. Ask how previous partners’ equity has performed.
• Employment agreement. The selling OD typically commits to continue practicing for a set period. Read the compensation terms, schedule expectations and what happens if you leave early.
• Deferred or contingent payments. Some buyers tie part of the price to future performance. Define the measures precisely and understand what control you will have over the results.
• Management structure. In states that restrict ownership by non-licensed entities, the buyer may use a management services agreement with a professional entity. Understand who owns the clinical entity and what fees flow to the management company.
• Real estate. If you own the building, you can sell it with the practice, keep it and lease it to the buyer, or sell it separately. Each option has different tax and income effects.

Comparing offers on these terms, not just the headline number, is where an adviser earns their fee. Two offers with the same headline can produce very different results once cash at closing, equity terms and employment conditions are compared.

What to ask every optometry buyer before you sign

Buyers will spend weeks examining your practice. You are entitled to examine them too, and the answers often matter as much as the price. Before signing a letter of intent, ask each serious buyer:

• How many practices have you acquired, and can I speak to some of the doctors? Ask for references from doctors who sold several years ago, not only recent partners, and ask them whether the buyer kept its promises on autonomy, staffing and equipment.
• What happens to my staff? Will the buyer keep everyone, change pay or benefits, or move billing and administrative roles to a central office?
• How will clinical decisions be made? Who decides which equipment to buy, which specialty services to offer and how many patients a doctor sees per day?
• What will change in the optical? Will you have to switch frame suppliers, labs or pricing? How will that affect patients who are used to your current selection?
• How will payer credentialing be handled? Has the buyer worked with your vision plans and insurers before, and how has it managed billing during past transitions?
• How is the buyer financed? A buyer carrying heavy debt or facing refinancing may pause acquisitions or cut costs after closing. If equity is part of your price, ask how the parent company is valued and when the owners expect to sell.
• What are the conditions to closing? Financing, landlord consent, regulatory approvals and diligence findings can all delay or derail a deal. Know which apply before you commit to exclusivity.

The answers help you compare offers that look similar on paper and avoid surprises after closing, when your bargaining position is weakest.

A 36-month preparation timeline

Working backward from the day you start talking to buyers, a practical sequence looks like this.

Three years out: build the team and clean up

• Recruit or develop associate ODs and give them time to build patient loyalty.
• Review associate agreements with employment counsel and update restrictive covenants where your state allows.
• Set up a documented process for eyeglass and contact lens prescription release and verification.
• Screen all staff against exclusion lists and put routine screening in place.
• Collect business associate agreements and complete a security risk assessment.

Two years out: financial discipline and growth

• Move to monthly accrual-based financials with revenue split by service line.
• Track the measures buyers care about: collections per doctor, optical sales per exam, recall rates and payer mix.
• Grow medical eye care and any specialty programs to reduce dependence on vision plans.
• Commission an outside coding audit and fix what it finds.
• Review your lease and start renewal or extension discussions if needed.

One year out: reduce dependence on you

• Shift your own patient load toward associates so the practice runs without you every day.
• Commission a sell-side quality of earnings review.
• Clean up the balance sheet, including receivables, deferred revenue and inventory valuation.
• Confirm the ownership structure allowed in your state and plan for it.
• Decide what role you want after closing.

Six months out: prepare to go to market

• Select an adviser and agree on the buyer list across individual buyers, management service organizations and ophthalmology-led groups.
• Prepare a confidential information memorandum and an anonymous summary.
• Assemble a data room with everything listed in the pre-LOI section above.

Going to market

• Approach buyers under confidentiality agreements and collect indications of interest.
• Hold management meetings with the most promising buyers and request letters of intent.
• Choose a buyer, sign a letter of intent and begin confirmatory diligence.
• Negotiate the purchase agreement, employment agreement and any management services documents.
• Start landlord consent, payer credentialing and Medicare enrollment changes early so they line up with closing.

How CT Acquisitions approaches an optometry exit

CT Acquisitions is an M&A advisory firm for founder-owned businesses, working sell side, buy side and on exit planning, with a network of 500+ buyers and capital partners. For optometry owners we begin with a readiness review covering associate retention, payer concentration, prescription rule compliance, coding documentation, ownership rules in your state and the quality of your financials. Where work is needed, we help you plan it before going to market.

We also help owners who are not yet sure they want to sell. A readiness review gives you a clear view of what your practice would look like to each type of buyer today, what would change that view, and how long the changes would take. Many owners use it to decide between selling now, bringing in an associate as a future buyer, or partnering with a group while they still want to practice for several more years.

When you are ready, we approach the buyer types that fit your practice, whether that is an associate or neighboring practice, an OD-focused management service organization or an ophthalmology-led group, under confidentiality and in parallel, so offers can be compared on cash at closing, equity terms, employment conditions and structure. No fee to you on buy-side introductions; sell-side mandates are paid on success at closing.

Frequently Asked Questions

How long should I plan for before selling my optometry practice to a private equity or OD-MSO buyer?

The owners who get top-quartile pricing start preparing 24 to 36 months before going to market. The minimum useful prep window is 12 months, because most of the high-leverage levers (lifting owner-OD production share below 35%, building optical capture rate to 75%+, shifting payer mix toward medical billing, launching a specialty service line, running a sell-side QoE) need 12+ months of clean trailing-twelve-months data to be credible to a buyer. Owners who try to sell in under 6 months typically leave 20% to 40% of enterprise value on the table.

What is a realistic EBITDA multiple for a $1M EBITDA optometry practice in 2026?

For a general commercial OD practice at $1M EBITDA in 2026, the range is 3x to 5x at the lower end and 5x to 7x at the add-on tier (FOCUS Investment Banking “Ophthalmology Practice Valuation 2026 Benchmarks”; Practice Exchange; CT Acquisitions cross-reference). The bottom of that range applies to solo practices with owner-OD dependence above 50%, vision-plan-only payer mix, and capture rate below 60%. The top applies to practices with associate ODs carrying production, 30%+ medical billing, 75%+ capture rate, and a membership plan in place. For specialty / medical-heavy OD practices at the same $1M EBITDA, the range shifts to 4x to 6x at the lower end and 6x to 9x at the add-on tier. The 36-month prep playbook moves you from the bottom of the band to the top.

Should I get a quality of earnings report done before going to market?

For optometry practices at $1M+ EBITDA, yes. A sell-side QoE costs $20K to $35K for a single-doc practice under $3M revenue with clean books, $25K to $60K typical for a healthy multi-location OD group $3M to $10M revenue, and up to $150K for complex multi-entity OD groups (Eton Venture Services 2025; Practice Exchange; Kahn Litwin Renza). The ROI is leverage. At a $1.5M EBITDA single-location optometry practice trading at 5x to 7x, a 0.5x multiple lift from clean QoE documentation equals $750K of sale price for a $25K to $40K investment. More importantly, a pre-market QoE surfaces revenue recognition issues on prepaid annual-supply CL, CPT-code utilization risk, frame inventory valuation gaps, and owner-OD compensation normalization while you can still fix them, rather than during exclusivity when the buyer re-trades the deal.

What percentage of recurring or membership revenue do PE buyers want to see in an optometry practice?

10%+ of the active patient base enrolled in an in-house membership plan at $35 to $49/mo, paired with 60%+ of contact lens patients on annual-supply commitments, is the threshold that signals defensible recurring revenue to a PE or OD-MSO buyer (BoomCloud; VisionHQ; multiple membership platform benchmarks). Membership patients see retention jump from approximately 50% to approximately 90% per BoomCloud research, and members also buy 90%+ of their eyewear in-house, which lifts capture rate. Estimate +0.5x to 1.0x EBITDA multiple uplift on a meaningful membership-plus-annual-supply program. On a $1.5M EBITDA practice that 0.5x to 1.0x equals $750K to $1.5M of additional sale price.

Do I need to hire an associate optometrist before I sell so I am no longer the production engine?

If your goal is to maximize price, yes, ideally 18 to 24 months pre-sale. Owner-OD production share is the single most-cited multiple haircut in optometry valuation literature (Practice Exchange; ODs on Finance; Arrowfish 2025). Owner above 40% production triggers post-close revenue deterioration modeling; above 50% can move the multiple down 1.0x to 2.0x or trigger structure renegotiation (heavy earnout, multi-year post-close employment commitment, larger holdback). On a $1.2M EBITDA practice that is $1.2M to $2.4M of price. Associate OD compensation runs 14% to 20% of gross revenue, typically 15% to 18% on production-based comp per Review of Optometric Business. The hire and patient transition (assign recall patients to the associate first) needs 12+ months of clean trailing data for the buyer’s diligence team to believe the production shift.

Should I sell my optical dispensary inventory and equipment with the practice or hold the real estate back?

Frame inventory and diagnostic equipment are almost always purchased with the practice, but the dispensary inventory is valued separately on a physical count plus wholesale cost basis at close (not included in the EBITDA multiple). Aged frames, consigned luxury frames (Cartier, Lindberg, Tom Ford, Maui Jim) that are vendor-owned rather than purchased, and lab work-in-progress all need to be isolated before the inventory count or the buyer adjusts purchase price downward. Real estate is a different question: holding the practice real estate separately in an LLC at fair market value triple-net rent is usually the higher-value path. This often lifts the implied EBITDA multiple on the operating practice by 0.5x to 1.0x because the buyer (most MSO platforms) does not want to underwrite real estate exposure. You then have three options at close: assign the lease, sell the real estate to the buyer at appraised value, or execute a sale-leaseback with a medical-office REIT (Global Medical REIT, Healthcare Realty, Welltower, Anchor Health Properties, MedCore Partners) at the same time as the operating practice sale. The sale-leaseback path can convert up to 100% of property market value as cash, vs. 70% to 80% LTV via traditional refinancing (Matthews; Northmarq medical sale-leaseback primers).

What to Do Next

The optometry owners who get the top-quartile multiple all do the same three things. They start preparing 24 to 36 months before they want to be out. They move owner-OD production below 35% by hiring associates 18 to 24 months pre-sale. And they invest in a sell-side QoE before any buyer sees a CIM.

The optometry buyer universe in 2026 is the deepest it has ever been: 40+ PE-backed eye care MSOs actively bidding, a fresh strategic floor set by Cencora’s $4.6B RCA acquisition at 18.4x EBITDA in January 2025 and McKesson’s $850M for 80% of PRISM Vision Holdings in April 2025, and demographic tailwinds (19% routine eye exam demand growth and 62% medical exam demand growth through 2040 per the AOA) that underwrite the underlying thesis. The owners who exit well over the next 36 months will be the ones who put the prep work in now.

If you are 12+ months from a potential exit and want a structured pre-sale optimization roadmap, CT Acquisitions has optometry practice operators in our partner network who run multi-quarter prep engagements. If you are 6 to 12 months out and ready to start the sell-side process, our M&A advisory team runs the buyer outreach. No fee to you on buy-side introductions; sell-side mandates are paid on success at closing. Either way, the first 30 minutes are free.